BCAL Diagnostics Future Growth

Future criteria checks 2/6

BCAL Diagnostics is forecast to grow earnings and revenue by 60% and 61.8% per annum respectively while EPS is expected to grow by 66.9% per annum.

Key information

60.0%

Earnings growth rate

66.9%

EPS growth rate

Biotechs earnings growth16.0%
Revenue growth rate61.8%
Future return on equityn/a
Analyst coverage

Low

Last updated22 Feb 2024

Recent future growth updates

No updates

Recent updates

Is BCAL Diagnostics (ASX:BDX) In A Good Position To Deliver On Growth Plans?

Aug 08
Is BCAL Diagnostics (ASX:BDX) In A Good Position To Deliver On Growth Plans?

Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Apr 07
Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

Dec 23
Here's Why We're Not Too Worried About BCAL Diagnostics' (ASX:BDX) Cash Burn Situation

Earnings and Revenue Growth Forecasts

ASX:BDX - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2026124441
6/30/20253-7-7-71
6/30/20243-4-3-31
12/31/20234-5-5-4N/A
9/30/20233-5-6-5N/A
6/30/20233-5-6-6N/A
3/31/20232-5-6-5N/A
12/31/20221-5-5-5N/A
9/30/20221-4-4-4N/A
6/30/20221-3-3-3N/A
3/31/20221-3-3-3N/A
12/31/20211-3-3-3N/A
9/30/20210-2-2-2N/A
6/30/20210-2-1-1N/A
3/31/20210-1-1-1N/A
12/31/20201000N/A
9/30/20200-100N/A
6/30/20200-1-1-1N/A
6/30/201900-1-1N/A
6/30/20180000N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BDX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: BDX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: BDX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: BDX's revenue (61.8% per year) is forecast to grow faster than the Australian market (5% per year).

High Growth Revenue: BDX's revenue (61.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BDX's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.